Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Nicotine Replacement Therapies May Aid In Harm Reduction - IoM

This article was originally published in The Tan Sheet

Executive Summary

Nicotine replacement therapies, including OTC smoking cessation products, should be evaluated for their potential to reduce the rate of cigarette smoking among individuals who are unable or unwilling to quit, the Institute of Medicine asserts in a report entitled Clearing the Smoke.

You may also be interested in...



Nicotine Replacement "Not First Choice" During Pregnancy - Duke's Slotkin

Doctors are recommending pregnant women use nicotine replacement therapies to stop smoking without fully considering their effect on the fetus, according to Theodore Slotkin, PhD, Duke University Medical Center. He spoke at a FDA seminar May 17 on the implications of smoking and nicotine replacement in pregnancy.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel